デフォルト表紙
市場調査レポート
商品コード
1571948

生体補綴の世界市場

Bioprosthetics

出版日
ページ情報
英文 92 Pages
納期
即日から翌営業日
適宜更新あり
生体補綴の世界市場
出版日: 2024年10月18日
発行: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
ページ情報: 英文 92 Pages
納期: 即日から翌営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

生体補綴の世界市場は2030年までに119億米ドルに達する

2023年に63億米ドルと推定される生体補綴の世界市場は、2030年には119億米ドルに達し、分析期間2023-2030年のCAGRは9.5%で成長すると予測されます。本レポートで分析したセグメントの1つである異種移植生体補綴は、CAGR 10.0%を記録し、分析期間終了までに83億米ドルに達すると予測されます。同種移植生体補綴セグメントの成長率は、分析期間中CAGR 8.4％と推定されます。

米国市場は16億米ドルと推定、中国はCAGR 14.1％で成長予測

米国の生体補綴市場は2023年に16億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに31億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは14.1%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.9%と8.5%と予測されています。欧州では、ドイツがCAGR約5.9%で成長すると予測されています。

世界の生物農薬市場- 主要動向と促進要因のまとめ

生物農薬はどのように農業に革命を起こしているのか？

生物農薬は、従来の化学農薬に代わる持続可能で環境に優しい農薬として、現代農業のゲームチェンジャーとして台頭してきています。微生物、植物抽出物、その他の有機化合物など、天然または生物学的起源に由来するこれらの農薬は、より特異的で環境に優しい方法で害虫を標的にします。生物農薬は、害虫、病気、雑草を効果的に駆除しながら、環境への悪影響を最小限に抑えるよう設計されています。人間や益虫、野生生物など、非標的生物に対する毒性が低いため、人気が高まっています。持続可能な農業への世界の注目が高まり、有機農産物への需要が高まるなか、生物農薬は総合的病害虫管理（IPM）プログラムに不可欠な要素となっています。これらの製品は農作物を保護するだけでなく、生物多様性や土壌の健全性もサポートするため、生産性と生態系責任の両立を目指す農家にとって重要なツールとなっています。農業界が化学農薬の使用削減を求める規制圧力の高まりに直面するなか、生物農薬は作物の収量と環境の両方を守るための実行可能な解決策を提供します。

最終用途はどのように生物農薬の採用を形成しているか？

生物農薬の用途はさまざまな農業分野で急速に拡大しており、中でも果物、野菜、特殊作物が需要の主要な牽引役となっています。これらの作物は病害虫に対して非常に敏感であることが多く、精密農業戦略の一環として適用される生物農薬の標的を絞った作用から大きな恩恵を受けています。例えば、有機農家や持続可能な農家は、有機認証を損なうことなく病害虫を管理するため、生物農薬殺虫剤、殺菌剤、除草剤の採用を増やしています。園芸分野では、観葉植物や芝を保護するために生物処理製品が広く使用されており、公共スペース、公園、ゴルフコースにより安全な代替手段を提供しています。さらにこれらの農薬は、蚊やその他の病気を媒介する昆虫を駆除することが重要な、公衆衛生における媒介性疾患の管理においても支持を集めています。畑作物だけでなく、生物農薬は温室栽培にも応用されています。温室栽培では、環境が制御されているため、害虫駆除と植物の健康のバランスを保つことが非常に重要です。多様な分野で生物農薬の使用が拡大していることは、現代農業における生物農薬の多用途性と重要性の高まりを浮き彫りにしています。

生物農薬の進歩において技術が果たす役割とは？

技術の進歩は、生物農薬の有効性と適用を強化し、農家にとってより信頼性が高く利用しやすいものにする上で重要な役割を果たしています。高度な発酵・製剤技術の開発により、微生物ベースの生物農薬の安定性、保存性、効力が改善され、農業への幅広い導入が可能になった。さらに、ドローンやセンサー技術などの精密農業における技術革新により、生物農薬のより的を絞った散布が可能になり、無駄が減り、必要な場所にのみ治療が施されるようになっています。この精密さは害虫駆除の効率を高めるだけでなく、農薬使用による環境フットプリント全体の削減にもつながります。さらに、バイオテクノロジーの進歩により、有益な生物にとって安全でありながら、抵抗性の害虫に対してより効果的な遺伝子組み換え生物農薬が開発されています。こうした技術革新は、AIを活用した予測モデルとともに、より優れた害虫モニタリングと農薬散布の正確なタイミングを可能にし、その効果を最大化します。また、デジタル農業ツールと生物農薬散布の統合が進むことで、農家はより持続可能な害虫管理方法を採用することができ、データ主導型農業に向けた世界の動向と一致しています。

生物農薬市場の成長を促進する要因は何か？

生物農薬市場の成長は、持続可能な農法に対する需要の増加、化学農薬使用に対する厳しい規制、有機食品や残留農薬のない食品への消費者の嗜好の変化など、いくつかの要因によってもたらされます。主な促進要因のひとつは、合成化学農薬に伴う環境・健康リスクに対する認識が高まり、消費者と政府の双方がより安全な代替農薬を求めるようになったことです。主要な農業経済国の規制機関は、従来の農薬の使用に対する規制を強化しており、その結果、生物農薬製品の採用が増加しています。さらに、有機栽培や持続可能な方法で栽培された食品に対する消費者の需要が高まっていることも、農家が害虫管理戦略の一環として生物農薬を取り入れることを後押ししています。もう1つの要因は、化学農薬に対する害虫抵抗性の蔓延が拡大していることで、新規の作用モードを持つ生物化ソリューションがより魅力的な選択肢となっています。バイオテクノロジーと製剤技術における技術革新も、これらの製品の有効性と保存性を向上させることで市場の成長に寄与しています。さらに、慣行農法と有機農法の両方における総合的有害生物管理（IPM）プログラムの拡大が、IPMが強調する持続可能で的を絞ったアプローチを補完するものとして、生物農薬の需要を押し上げています。農業セクターが持続可能性と生産性を優先し続けるなか、生物農薬市場は着実に成長すると予想されます。

調査対象企業の例（注目の36社）

  • Aortech International Plc
  • Braile Biomedica, Inc.
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Ethicon, Inc.
  • Humacyte, Inc.
  • JenaValve Technology GmbH
  • Labcor Laboratorios Ltd.
  • LeMaitre Vascular, Inc.
  • LifeCell International

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP21347

Global Bioprosthetics Market to Reach US$11.9 Billion by 2030

The global market for Bioprosthetics estimated at US$6.3 Billion in the year 2023, is expected to reach US$11.9 Billion by 2030, growing at a CAGR of 9.5% over the analysis period 2023-2030. Xenograft Bioprosthetics, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$8.3 Billion by the end of the analysis period. Growth in the Allograft Bioprosthetics segment is estimated at 8.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 14.1% CAGR

The Bioprosthetics market in the U.S. is estimated at US$1.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.1 Billion by the year 2030 trailing a CAGR of 14.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 8.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.9% CAGR.

Global Biorational Pesticides Market – Key Trends & Drivers Summarized

How Are Biorational Pesticides Revolutionizing Agriculture?

Biorational pesticides are emerging as a game-changer in modern agriculture, offering a sustainable and environmentally friendly alternative to traditional chemical pesticides. These pesticides, derived from natural or biological origins such as microorganisms, plant extracts, or other organic compounds, target pests in a more specific and eco-friendly manner. Biorational pesticides are designed to minimize negative environmental impacts while effectively controlling pests, diseases, and weeds. They are gaining popularity due to their reduced toxicity to non-target organisms, including humans, beneficial insects, and wildlife. With the increasing global focus on sustainable agriculture and the growing demand for organic produce, biorational pesticides are becoming an integral part of Integrated Pest Management (IPM) programs. These products not only help protect crops but also support biodiversity and soil health, making them a critical tool for farmers seeking to balance productivity with ecological responsibility. As the agricultural industry faces increasing regulatory pressures to reduce chemical pesticide use, biorational pesticides offer a viable solution to safeguard both crop yields and the environment.

How Are End-Use Applications Shaping the Adoption of Biorational Pesticides?

The application of biorational pesticides is expanding rapidly across various agricultural sectors, with fruits, vegetables, and specialty crops being key drivers of demand. These crops, which are often highly sensitive to pests and diseases, benefit significantly from the targeted action of biorational pesticides, which are applied as part of precision agriculture strategies. For example, organic and sustainable farmers are increasingly adopting biorational insecticides, fungicides, and herbicides to manage pests and diseases without compromising their organic certification. In horticulture, biorational products are widely used to protect ornamentals and turf, offering a safer alternative for public spaces, parks, and golf courses. Additionally, these pesticides are gaining traction in the management of vector-borne diseases in public health, where controlling mosquitoes and other disease-carrying insects is critical. Beyond field crops, biorational pesticides are finding applications in greenhouse cultivation, where maintaining a balance between pest control and plant health is crucial due to the controlled environment. The expanding use of biorational pesticides across diverse sectors highlights their versatility and growing importance in modern agriculture.

What Role Does Technology Play in Advancing Biorational Pesticides?

Technological advancements are playing a crucial role in enhancing the effectiveness and application of biorational pesticides, making them more reliable and accessible for farmers. The development of advanced fermentation and formulation technologies has improved the stability, shelf-life, and potency of microbial-based biorational products, enabling their broader adoption in agriculture. Additionally, innovations in precision agriculture, such as drones and sensor technologies, are enabling more targeted application of biorational pesticides, reducing wastage and ensuring that the treatments are applied only where needed. This precision not only enhances pest control efficiency but also reduces the overall environmental footprint of pesticide usage. Furthermore, advancements in biotechnology have led to the creation of genetically engineered biopesticides that are more effective against resistant pests while remaining safe for beneficial organisms. These innovations, along with AI-driven predictive models, allow for better pest monitoring and more accurate timing of pesticide applications, maximizing their efficacy. The growing integration of digital farming tools with biorational pesticide application is also helping farmers adopt more sustainable pest management practices, aligning with global trends toward data-driven agriculture.

What Factors Are Driving Growth in the Biorational Pesticides Market?

The growth in the biorational pesticides market is driven by several factors, including increased demand for sustainable farming practices, stringent regulations on chemical pesticide use, and shifting consumer preferences towards organic and residue-free food. One of the key drivers is the growing awareness of the environmental and health risks associated with synthetic chemical pesticides, prompting both consumers and governments to seek safer alternatives. Regulatory bodies in major agricultural economies are tightening restrictions on the use of traditional pesticides, leading to increased adoption of biorational products. Furthermore, the rising consumer demand for organic and sustainably grown food is pushing farmers to embrace biorational pesticides as part of their pest management strategy. Another factor is the increasing prevalence of pest resistance to chemical pesticides, which has made biorational solutions, with their novel modes of action, a more attractive option. Technological innovations in biotechnology and formulation techniques are also contributing to market growth by improving the efficacy and shelf-life of these products. Additionally, the expansion of Integrated Pest Management (IPM) programs in both conventional and organic farming is driving the demand for biorational pesticides, as they complement the sustainable and targeted approach that IPM emphasizes. As the agricultural sector continues to prioritize sustainability and productivity, the market for biorational pesticides is expected to grow steadily.

Select Competitors (Total 36 Featured) -

  • Aortech International Plc
  • Braile Biomedica, Inc.
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Ethicon, Inc.
  • Humacyte, Inc.
  • JenaValve Technology GmbH
  • Labcor Laboratorios Ltd.
  • LeMaitre Vascular, Inc.
  • LifeCell International

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Bioprosthetics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases and Aging Population Propels Demand for Bioprosthetic Heart Valves
    • Technological Advancements in Tissue Engineering Drive Innovation in Next-Generation Bioprosthetics
    • Growing Preference for Minimally Invasive Surgeries Spurs Adoption of Bioprosthetic Implants
    • Increasing Use of Bioprosthetic Materials in Orthopedic Applications Expands the Addressable Market
    • Improved Biocompatibility and Longevity of Bioprosthetics Strengthens Their Adoption in Cardiovascular and Orthopedic Surgeries
    • Growing Focus on Customized Bioprosthetic Solutions for Personalized Medicine Creates New Market Opportunities
    • Rising Demand for Aesthetic and Functional Bioprosthetics in Reconstructive Surgeries Drives Market Growth
    • Advances in Xenotransplantation Technologies Expand the Development and Adoption of Bioprosthetic Devices
    • Increasing R&D in Biomaterials and Biopolymer Technologies Propels Innovation in Bioprosthetic Design
    • Favorable Reimbursement Policies in Developed Markets Drive Adoption of Bioprosthetic Implants in Healthcare Systems
    • Growing Role of 3D Printing in Manufacturing Custom Bioprosthetics Expands Opportunities for Personalized Implants
    • Increasing Incidence of Sports Injuries and Trauma Surgeries Generates Demand for Bioprosthetic Ligaments and Tendons
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Bioprosthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Bioprosthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Bioprosthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Xenograft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Xenograft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Xenograft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Allograft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Allograft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Allograft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Plastic Surgery & Wound Healing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Plastic Surgery & Wound Healing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Plastic Surgery & Wound Healing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Bioprosthetics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • JAPAN
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • CHINA
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • EUROPE
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Bioprosthetics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Bioprosthetics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Bioprosthetics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • FRANCE
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: France 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • GERMANY
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: UK 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Spain 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Russia 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Bioprosthetics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Bioprosthetics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Bioprosthetics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Australia 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • INDIA
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: India 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: South Korea 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Bioprosthetics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Bioprosthetics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Latin America 16-Year Perspective for Bioprosthetics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Argentina 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Brazil 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Mexico 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Rest of Latin America 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Bioprosthetics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Bioprosthetics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Middle East 16-Year Perspective for Bioprosthetics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Iran 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Israel 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Saudi Arabia 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: UAE 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Middle East 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • AFRICA
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Africa 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030

IV. COMPETITION